Related references
Note: Only part of the references are listed.3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online
M. Coppola et al.
TOXICOLOGY LETTERS (2012)
Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States
Henry A. Spiller et al.
CLINICAL TOXICOLOGY (2011)
Cathinone derivatives: A review of their chemistry, pharmacology and toxicology
John P. Kelly
DRUG TESTING AND ANALYSIS (2011)
Ivory wave: the next mephedrone?
Mark Durham
EMERGENCY MEDICINE JOURNAL (2011)
Drugs for youth via Internet and the example of mephedrone
I. Vardakou et al.
TOXICOLOGY LETTERS (2011)
An Overview of Khat
Shantala Shailendra Magdum
ADDICTIVE DISORDERS & THEIR TREATMENT (2011)
4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse
Gregory C. Hadlock et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats
Justin T. Gass et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Extended access to amphetamine self-administration increases impulsive choice in a delay discounting task in rats
Cassandra D. Gipson et al.
PSYCHOPHARMACOLOGY (2009)
Escalation of methamphetamine self-administration in rats: a dose-effect function
O Kitamura et al.
PSYCHOPHARMACOLOGY (2006)
1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors
PC Meltzer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)